Receipt of notification from a shareholder under Article 69 of the Act on Public Offering
Current Report No. 37/2019
Legal basis: Article 70(1) the Act on Public Offering – acquisition or disposal of a significant stake
The Management Board of Medicalgorithmics S.A. (“Company”) announces that on 4 October 2019 the Company received a notification from Powszechne Towarzystwo Emerytalne PZU S.A. (“PTE PZU”) acting on behalf of Otwarty Fundusz Emerytalny PZU “Złota Jesień” (“OFE PZU”) pursuant to Article 69(1)(1) and Article 69(2)(1)(a) of the Act of 29 July 2005 on public offering and terms and conditions governing the introduction of financial instruments into organized trading and public limited companies (consolidated text: Jurnal of Laws of 2019, item 623) (“Act on Public Offering”).
PTE PZU notifies that as the result of completing the purchase of 7 500 (seven thousand five hundred) shares of the Company on the Warsaw Stock Exchange on 30 September 2019, after settling the transaction on 2 October 2019, OFE PZU increased its share held in the Company at least 2% of the total number of votes. Before the transaction, OFE PZU held over 10% of the total number of votes.
Before closing the transaction, OFE PZU held 436 861 shares of the Company , representing 12,11 % of the Company share capital and 436 861 votes at the Company’s general meeting, constituting 12,11 % of the total number votes at the Company’s general meeting.
After closing the transaction, OFE PZU holds 444 361 shares of the Company, representing 12,32 % of the Company’s share capital and 444 361 votes at the Company’s general meeting, constituting 12,32 % of the total number of votes at the Company’s general meeting.
OFE PZU communicated that:
- it does not have any subsidiaries holding shares of the Company;
- the situation referred to in Article 69(4)(6) of the Act on Public Offering has not taken place;
- it does not hold any financial instruments referred to in Article 69b(1) items (1) and (2) of the Act on Public Offering.